Delayed Graft Function in Living-Donor Kidney Transplant: A Middle Eastern Perspective

Area of Science:

• Nephrology
• Transplantation Medicine
• Public Health

Background:

• Living-donor kidney transplantation is increasing due to unmet renal transplant needs.
• Delayed graft function (DGF) is well-studied in deceased-donor transplants but less understood in living-donor cases.
• Awareness and evidence regarding DGF in living-donor kidney transplants are limited.

Purpose of the Study:

• To emphasize the critical role of DGF as a determinant of outcomes in living-donor kidney transplantation.
• To review the current evidence on DGF in living-donor kidney transplants, with a focus on Middle Eastern studies.
• To identify incidence, impact, risk factors, and prevention strategies for DGF in this patient population.

Main Methods:

• An exhaustive literature search of online medical databases was conducted.
• Search criteria focused on DGF after living-donor kidney transplantation, including studies from the Middle East.
• Data synthesis on incidence, impact, risk factors, and prevention modalities.

Main Results:

• Contemporary DGF incidence rates in the Middle East appear higher than in other regions.
• While lower than in deceased-donor transplants, DGF significantly affects graft rejection and survival.
• Specific risk factors for DGF in living-donor kidney transplants are not well-defined but are crucial for strategy development.

Conclusions:

• DGF is a significant clinical concern in living-donor kidney transplantation, necessitating specific treatment protocols.
• Higher DGF incidence in the Middle East warrants regional attention and further investigation.
• More research is urgently needed to fully understand and address DGF in living-donor kidney transplants.